fda approval of tirzepatide for weight loss Approves Zepbound: A New Medication by Eli Lilly FDA approves Lilly's Zepbound (tirzepatide)

Among incretins, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) serve as key regulators of metabolism (8), and GLP-1 receptor agonists (GLP-1RAs) have been established as first-line therapies for type 2 diabetes (T2D) and obesity (9)

This is one of the most overlooked causes of tiredness on Mounjaro

The optic nerve head in glaucoma: role of astrocytes in tissue remodelig

This multicomponent approach should include dietary advice, support for increasing physical activity (tailored to individual capability), and behavioural strategies to support long-term lifestyle change

This property is important when planning experimental protocols

But the pattern is uncomfortably familiar: a medicine pitched as the simple solution to a complex problem, rolled out at scale, leaving behind long-term dependence and economic side-effects nobody planned for